Eagle Pharmaceuticals Inc expected to post earnings of $1.09 a share - Earnings Preview

Eagle Pharmaceuticals

03/11/2023 19:31

* Eagle Pharmaceuticals Inc  EGRX.OQ   EGRX.O  is expected
to show
a fall in quarterly revenue when it reports  results 
    * The Woodcliff Lake New Jersey-based  company is expected
to
report  a 4.7% decrease in revenue to $62.826 million from $65.9
million a year ago, according to the estimate from one analyst,
based on LSEG data. 
    * ​Refinitiv's mean analyst estimate for Eagle
Pharmaceuticals Inc
is for earnings of $1.09 per share. 
    * The one available analyst rating on the shares is "strong
buy".  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​

This summary was machine generated November 3 at 19:31 GMT.  All
figures in US dollars  unless otherwise stated